Somatrogon
- Generic Name
- Somatrogon
- Brand Names
- Ngenla
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1663481-09-1
- Unique Ingredient Identifier
- 6D848RA61B
- Background
Somatrogon is a long-acting recombinant human growth hormone. Growth hormone is a peptide hormone secreted by the pituitary gland that plays a crucial role in promoting longitudinal growth during childhood and adolescence and regulating metabolic function in adulthood. Recombinant growth hormone therapy for growth hormone deficiency and other conditions has ...
- Indication
Somatrogon is indicated for the long-term treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone (growth hormone deficiency).
- Associated Conditions
- Growth Failure
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath